Commentary. Molecular pharmacology of beta-adrenergic receptors--a status report.
D000262:Adenylyl Cyclases / Q000302:isolation & purification / Q000378:metabolism / Q000502:physiology; D000318:Adrenergic beta-Agonists / Q000378:metabolism / Q000494:pharmacology; D001665:Binding Sites; D001667:Binding, Competitive; D002395:Catecholamines / Q000378:metabolism / Q000494:pharmacology; D002846:Chromatography, Affinity; D004789:Enzyme Activation / Q000187:drug effects; D006150:Guanine Nucleotides / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000494:pharmacology; D008055:Lipids / Q000494:pharmacology; D009638:Norepinephrine; D011485:Protein Binding; D011941:Receptors, Adrenergic / Q000187:drug effects; D011956:Receptors, Cell Surface; D013268:Stimulation, Chemical
D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D006150:Guanine Nucleotides; D008055:Lipids; D011941:Receptors, Adrenergic; D011956:Receptors, Cell Surface; D006160:Guanosine Triphosphate; D000262:Adenylyl Cyclases; D009638:Norepinephrine